» Articles » PMID: 7599794

Well-differentiated Endocrine Tumours of the Middle Ear and of the Hindgut Have Immunocytochemical and Ultrastructural Features in Common

Overview
Journal Virchows Arch
Date 1995 Jan 1
PMID 7599794
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The immunocytochemical analysis of two cases of well-differentiated endocrine tumours (carcinoids) of the middle ear revealed predominant cell populations producing pancreatic polypeptide (PP)-related peptides, glucagon-related peptides, and serotonin (the latter only in one case). In consecutive sections PP- and glucagon-related immunoreactivities mainly colocalized in the same tumour cells. Ultrastructurally tumour cells were characterized by medium-sized to large granules of moderate to high density, on which PP and glicentin were localized by the immunogold technique. No amphicrine cells were found. These features are consistent with those of similar tumours in the rectal mucosa that are mainly composed of L cells coexpressing both PP-related and glucagon-related peptides. Additional tumour antigens of hindgut type detected immunohistochemically were prostatic acid phosphatase and CAR-5 mucin. Expression of the CAR-5 antigen was also found in samples of normal middle ear mucosa, in which endocrine cells have not been identified. In case 1 peritumoral mucosal invaginations showed a proliferation of endocrine cells identical immunophenotypically to tumour cells, possibly representing a precursor lesion. It is concluded that well-differentiated endocrine tumours of the middle ear are a distinct pathological entity characterized by multiple hormone production, typically involving three classes of hormones (pancreatic polypeptide-related peptides, glucagon-related peptides, and serotonin) of the hindgut endocrine system.

Citing Articles

Neuroendocrine neoplasms of the head and neck: some suggestions for the new WHO classification of head and neck tumors.

Xu B, Chetty R, Perez-Ordonez B Head Neck Pathol. 2014; 8(1):24-32.

PMID: 24595420 PMC: 3950384. DOI: 10.1007/s12105-014-0531-y.


Carcinoid tumor of the middle ear in a 28-year-old patient.

Blaker H, Dyckhoff G, Weidauer H, Otto H Pathol Oncol Res. 1998; 4(1):40-3.

PMID: 9555120 DOI: 10.1007/BF02904694.

References
1.
Bordi C, Yu J, Baggi M, Davoli C, Pilato F, Baruzzi G . Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer. 1991; 67(3):663-72. DOI: 10.1002/1097-0142(19910201)67:3<663::aid-cncr2820670323>3.0.co;2-l. View

2.
Fiocca R, Rindi G, Capella C, Grimelius L, Polak J, Schwartz T . Glucagon, glicentin, proglucagon, PYY, PP and proPP-icosapeptide immunoreactivities of rectal carcinoid tumors and related non-tumor cells. Regul Pept. 1987; 17(1):9-29. DOI: 10.1016/0167-0115(87)90029-2. View

3.
Inoue S, Tanaka K, Kannae S . Primary carcinoid tumor of the ear. Virchows Arch A Pathol Anat Histol. 1982; 396(3):357-63. DOI: 10.1007/BF00431394. View

4.
Maschek H, Schrader B, Werner M, Franke K, Georgii A . [Carcinoid of the middle ear: a rare tumor with biphasic differentiation. Case report with special reference to immunohistochemistry and electron microscopy]. HNO. 1992; 40(10):405-9. View

5.
Fiocca R, Capella C, Buffa R, Fontana R, Solcia E, Hage E . Glucagon-, glicentin-, and pancreatic polypeptide-like immunoreativities in rectal carcinoids and related colorectal cells. Am J Pathol. 1980; 100(1):81-92. PMC: 1903769. View